MedAdvisor Solutions Showcases Industry's First AI-Driven Medication Advisor
Designed To Support Patient Engagement And Improve Access To Medication Information
The first-of-its-kind, AI-driven medication advisor offers personalized engagement to support patients' healthcare journeys while also reducing pharmacist burden. This innovative technology enhances interactions, from personalized conversations about medication management to answers related to complex health inquiries. By utilizing the interactive advisor, pharmacies can elevate adherence, awareness, and education programs.
The medication advisor's unique data architecture creates a secure environment for patient insights and proprietary pharmacy content, ensuring HIPAA compliance and minimizing the risk of inaccuracies and bias. Its responses are derived from a curated, customizable repository of approved content, offering pharmacies flexibility in incorporating vetted information and underscoring MedAdvisor Solutions' unparalleled commitment to information security and privacy.
"The integration of advanced AI solutions into pharmacies' patient engagement services will help to improve customer experience and reduce burden on pharmacy staff," said
BEN's safe, conversational, human-modeled avatar serves as the foundation of the medication advisor's capabilities. Proprietary AI technology enables the intelligent and communicative medication advisor to serve as a resource for patients and pharmacists by providing 24/7, multilingual support.
One important way the advisor supports pharmacies, and their patients is through vaccination education, engagement, and appointment scheduling. By delivering credible information, alleviating patient concerns, and streamlining the vaccination process, the advisor gives time back to the pharmacists to focus on more urgent patient interactions. Its versatile design caters to patients of all ages, offering clear information for older adults and a familiar, conversational interface for younger patients.
At the NACDS conference, attendees will have an exclusive opportunity to engage with a life-sized version of the medication advisor, known as Sandy. They can see firsthand how it addresses questions about vaccines, including COVID-19, flu, and RSV, and learn how it schedules vaccination appointments through text and voice interfaces.
"Patients deserve quick and accurate answers regarding their healthcare," said
The advisor is one of the first offerings from MedAdvisor's innovative partnership with BEN. Visit MedAdvisor Solutions at booth #516 during NACDS TSE 2024
About MedAdvisor Solutions
MedAdvisor Solutions, formerly Adheris Health, is a global leader of pharmacy-driven patient engagement solutions that provide individualized patient experiences to simplify the patient medication journey. Our solutions utilize an empathetic, data-driven approach to engagement and an innovative, patient-centric digital experience that empower the pharmacy of the future and inspire lasting behavior change. MedAdvisor Solutions works with over 37,000 pharmacies across the US,
In
About BEN
Brand Engagement Network (BEN), NASDAQ: BNAI, is an emerging provider of safe and secure generative AI for businesses and consumers, headquartered in
Additional information about BEN can be found here: https://beninc.ai/
This press release contains "forward looking statements" as defined in
MedAdvisor Press Contact:
Email: [email protected]
Phone: 781-248-9455
View original content to download multimedia:https://www.prnewswire.com/news-releases/medadvisor-solutions-showcases-industrys-first-ai-driven-medication-advisor-302220532.html
SOURCE MedAdvisor Solutions
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pillsbury Notice of Data Breach
- eGhanaVisa.com Expands Online Visa Assistance Services with Card and USDT Payment Options
- Recapture Isn't Robin Hood: Missy Bender Unpacks Texas' $3B School Finance Myth
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share